I-Retinoic Acid CAS 302-79-4 Ubunyulu > 99.5% (HPLC) Umgangatho ophezulu weFactory
Umenzi, uMgangatho oPhezulu, iMveliso yoRhwebo
Igama leKhemikhali: I-Retinoic Acid CAS: 302-79-4
Igama leMchiza | I-Retinoic Acid |
Izithethantonye | I-Acid yeVithamini;yonke i-trans-Retinoic Acid;iTretinoin;ATRA |
Inombolo yeCAS | 302-79-4 |
Inombolo yeCAT | RF-PI1161 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C20H28O2 |
Ubunzima beMolekyuli | 300.44 |
Ukunyibilika | Ukunganyibiliki emanzini;Inyibilika kwi-Etere, iNyibilika kancinane kuTywala |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo oMthubi |
I-IR yokufunxa Spectrum | Qhagamshelana ne-Reference Spectrum |
Indawo yokunyibilika | 179.0 ~ 183.0℃ |
Ubunyulu / Indlela yokuHlalutya | > 99.5% (HPLC) (Ibalwe kwisiseko somisiwe) |
Ilahleko ekomisweni | ≤0.50% |
Intsalela kwi-Ignition | ≤0.10% |
Iintsimbi ezinzima | ≤10ppm |
Arsenic | ≤3ppm |
Inkokeli | ≤3ppm |
Isotretinoin | ≤5.0% |
Tretinoin | ≤0.20% |
Ukungcola Okungaziwayo Ongatshatanga | ≤0.20% |
Ukungcola ngokupheleleyo | ≤0.50% (Ngaphandle kwe-Isotretinoin) |
Iimvavanyo zeMicrobiological | |
Ubalo lwePleti luphelele | <100 cfu/g |
Igwele kunye nokungunda | <100 cfu/g |
E.Coli | Ukungabikho |
Salmonella | Ukungabikho |
Izinyibilikisi ezishiyekileyo | |
IAcetaldehyde | ≤15ppm |
I-Ethyl Acetate | ≤5000ppm |
Ukunyibilika kwi-CHCL3 | Mthubi ukuya kumthubi-oluhlaza, Kucacile, 50mg/ml |
Umgangatho woVavanyo | uMgangatho woShishino;USP |
Ukusetyenziswa | API;AbaPhakathi bamayeza |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.
I-Retinoic Acid (i-CAS: i-302-79-4) isetyenziswe ngokubanzi kwintsimi yonyango, ngokukodwa isetyenziselwa ukunyanga i-dermatonosus njenge-acne, ichthyosis kunye ne-psoriasis engaqhelekanga, njl. olunye ulusu olungenampilo.I-Retinoic Acid isetyenziselwa iziyobisi ze-keratinocytes-resistant kunye ne-cell-induced different drug.Ifumaneka njengekhilimu okanye ijeli.Ikwasetyenziselwa ukunyanga i-acute promyelocytic leukemia.Inokukhuthaza ukukhula kolusu kwaye igcine i-epidermic iqhelekile.Inokucothisa inkqubo yokuguga kwesikhumba kwi-solarization, isuse imibimbi emincinci.Inokunciphisa uburhabaxa bolusu, ngoko ulusu luya kuba bomvu.Susa ukungcola okuqokelelwe kwi-pores, unciphise ama-pores kwaye ube nefuthe le-antibacterial.